Form 8-K - Current report:
SEC Accession No. 0001213900-24-002287
Filing Date
2024-01-09
Accepted
2024-01-09 16:05:35
Documents
13
Period of Report
2024-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191393-8k_augmedix.htm   iXBRL 8-K 34317
2 SIXTH OMNIBUS AMENDMENT, ENTERED INTO ON JANUARY 5, 2024, BY AND AMONG AUGMEDIX ea191393ex10-1_augmedix.htm EX-10.1 18247
  Complete submission text file 0001213900-24-002287.txt   231853

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE augx-20240105.xsd EX-101.SCH 3015
4 XBRL LABEL FILE augx-20240105_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE augx-20240105_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT ea191393-8k_augmedix_htm.xml XML 3410
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

EIN.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 24523289
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)